MWA
ABBV icon

Medallion Wealth Advisors’s AbbVie ABBV Stock Holding History

Medallion Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$554K Sell
2,546
-87
-3% -$19.3K 0.18% 116
2025
Q4 		$602K Sell
2,633
-77
-3% -$17.5K 0.2% 109
2025
Q3 		$627K Sell
2,710
-3
-0.1% -$611 0.22% 108
2025
Q2 		$513K Sell
2,713
-92
-3% -$17.1K 0.2% 117
2025
Q1 		$581K Buy
2,805
+520
+23% +$101K 0.26% 92
2024
Q4 		$427K Buy
+2,285
New +$420K 0.21% 107

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Medallion Wealth Advisors's ABBV Position: Q1 2026 in Review

Medallion Wealth Advisors reduced its AbbVie (ABBV) stake by 3.3% in Q1 2026, selling an estimated $19.3K and leaving 2,546 shares worth $554K. The position accounts for 0.18% of the portfolio, ranked #116.

Medallion Wealth Advisors first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $627K in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Medallion Wealth Advisors held 2,546 shares of AbbVie worth $554K as of Q1 2026.
  • Medallion Wealth Advisors sold 87 AbbVie shares in Q1 2026, an estimated $19.3K.
  • AbbVie made up 0.18% of Medallion Wealth Advisors's portfolio in Q1 2026, its #116 holding.
  • Medallion Wealth Advisors first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • Medallion Wealth Advisors's AbbVie position peaked at $627K in Q3 2025.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Medallion Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.